Therefore, we speculated that M2 type TAM-derived exosomes may enhance osimertinib resistance in NSCLC by regulating the MSTRG.292666.16/miR-6386-5p/MAPK8IP3 axis. This evidence concerns the gene MAPK8IP3 and non-small cell lung carcinoma.